CoverageForm 410-K10-Q8-K13D13G13F

CSTM Constellium Se - 8-K

Filed May 21, 2026. See issuer overview · financials · original on SEC.gov ↗
Accession
0001563411-26-000174
5.079.01

Item 5.07 - Submission of Matters to a Vote of Security Holders

666 words

Item 5.07

Submissions of Matters to a Vote of Security Holders

Constellium SE (the “Company”) held its Annual General Meeting of Shareholders on May 21, 2026. The proposals

for the appointment of Ingrid Joerg and the re-appointment of John Ormerod to the Company’s Board of Directors

for a period of three years following the Annual General Meeting, passed.

The Company’s shareholders approved, on an advisory basis, “one year” as the frequency for holding an advisory

(non-binding) vote on the compensation of the Company’s named executive officers. In light of such vote, the

Company has determined to hold the advisory (non-binding) vote on the compensation of the Company’s named

executive officers every year. The results for the remainder of the proposals are as set forth below.

* For the purposes of French law, broker non-votes are treated as abstentions. Therefore, in terms of the voting

results, broker non-votes, like other abstentions, were not counted as a vote cast on the applicable proposal.

The voting results are as follows:

1.

Ratification of the interim appointment of Ms. Ingrid Joerg as a director

Voted For

Voted Against

Abstained

Broker Non-Votes*

97,942,587

320,964

80,305

10,462,884

2.

Appointment of Ms. Ingrid Joerg as a director for a term of three years

Voted For

Voted Against

Abstained

Broker Non-Votes*

97,919,555

343,694

80,607

10,462,884

3.

Re-appointment of Mr. John Ormerod as a director for a term of three years

Voted For

Voted Against

Abstained

Broker Non-Votes*

82,318,163

15,907,876

117,817

10,462,884

4.

Approval, on an advisory (non-binding) basis, of the 2025 compensation of the Company’s named executive

officers

Voted For

Voted Against

Abstained

Broker Non-Votes*

79,852,601

5,788,962

12,702,293

10,462,884

5.

Advisory (non-binding) vote to hold an advisory (non-binding) vote on the compensation of the Company’s

named executive officers every year

Voted For

Voted Against

Abstained

Broker Non-Votes*

98,273,291

31,220

39,345

10,462,884

6.

Advisory (non-binding) vote to hold an advisory (non-binding) vote on the compensation of the Company’s

named executive officers every two years

Voted For

Voted Against

Abstained

Broker Non-Votes*

2,204,018

95,895,777

244,061

10,462,884

7.

Advisory (non-binding) vote to hold an advisory (non-binding) vote on the compensation of the Company’s

named executive officers every three years

Voted For

Voted Against

Abstained

Broker Non-Votes*

2,195,685

95,903,685

244,486

10,462,884

8.

Approval of the statutory financial statements and transactions for the fiscal year ended December 31, 2025

Voted For

Voted Against

Abstained

107,959,981

8,556

838,203

9

Approval of the consolidated financial statements and transactions for the fiscal year ended December 31,

2025

Voted For

Voted Against

Abstained

107,958,765

8,373

839,602

10.

Discharge (quitus) of the directors, the Chief Executive Officer, and the Statutory Auditors of the Company in

respect of the performance of their duties for the fiscal year ended December 31, 2025

Voted For

Voted Against

Abstained

Broker Non-Votes*

84,508,508

13,015,971

819,377

10,462,884

11.

Allocation of the results of the Company for the fiscal year ended December 31, 2025

Voted For

Voted Against

Abstained

108,658,184

9,365

139,191

12.

Approval of the aggregate maximum amount of the directors’ annual fixed fees

Voted For

Voted Against

Abstained

Broker Non-Votes*

98,208,852

41,092

93,912

10,462,884

13.

Authorization to be given to the Board of Directors for the repurchase by the Company of its own shares in

accordance with article L. 225-209-2 of the French Commercial Code

Voted For

Voted Against

Abstained

108,617,538

23,922

165,280

14.

Authorization to be given to the Board of Directors to reduce the Company’s share capital by canceling shares

acquired pursuant to the authorization for the Company to repurchase its own shares in accordance with the

provisions of article L. 225-209-2 of the French Commercial Code

Voted For

Voted Against

Abstained

108,728,505

20,320

57,915

15.

Authorization to be given to the Board of Directors to reduce the Company’s share capital by canceling the

shares acquired by the Company pursuant to the provisions of article L. 225-208 of the French Commercial

Code

Voted For

Voted Against

Abstained

108,724,554

24,190

57,996

16

Powers to carry out formalities

Voted For

Voted Against

Abstained

Broker Non-Votes*

98,227,432

8,580

107,844

10,462,884

Item 9.01 - Financial Statements and Exhibits

37 words

Item 9.01

Financial Statements and Exhibits

(d)  Exhibits

The following exhibits are furnished with this report on Form 8-K:

Exhibit No.

Description

104

The cover page of this Current Report on Form 8-K, formatted in Inline XBRL